People inform
Shutterstock/David MG
Semaglutide really seems to help people addicted to Alcohol Reducing their amount, according to the first random clinical trial of the property for this purpose.
It was sold under commercial names including Wegovy and OzemPIC, and Damascus works by simulating the intestine hormone called Petide-1 resembling Glp-1, and therefore the artistic term because it is against GLP-1 receptors. The drug was used for the first time to treat type 2 diabetes, but because it reduces appetite, wegov has now been licensed for weight loss In eight countries. Smaglutide also showed hints of extraordinary help Number of medical cases.
When it comes to alcohol, the 2024 study of 84,000 people fasted OzemPIC or Wegovy with a Low risk of alcohol addiction. Promising because this result showed a relationship instead of causation.
But now, Christian Hindershot At the University of Southern California and his colleagues, he completed the first random clinical trial for the effect of slajlotide on alcohol abuse, a type of study that can bother causation.
Their trial included 48 people in the United States, who were diagnosed with the condition, including 34 women and 14 men. Half receiving a low -dose weekend of Semaglutide for nine weeks and the rest was Fake Injections.
Those in Semaglutide consumes less drinks in the drinking session, and they have reduced the intense desire for alcohol in alcohol compared to those in the imaginary medicine.
“We had no evidence of significant harmful effects or safety concerns with the drug in this category of the population and we found in general that through many different drinking results, it reduces the amount of alcohol that people have consumed,” says Hindershot.
“The results are promising,” he says Rong Show At the College of Medicine at QISRER RISERF, Ohio. “Despite the size of the small sample, this random clinical experience highlights the therapeutic capabilities of the Druze in the treatment of alcohol abuse.”
Next Ziad “The study adds” another evidence that the GLP-1ras [GLP-1 receptor agonists] It may be useful in addiction disorders. “
He says that there are greater studies to confirm work, and answer questions about whether people increase their drinking if they come out of Smaglutide and what may be its effects in the long run, especially fears about the loss of their loss Bone and muscle block.
Hindershot says, the study should be treated as a promising initial evidence, but more research is needed. He says that people should not start taking the gruesteid for alcohol problems.
“This is the first study like this and the people are excited about that, but we have agreed to effective and effective alcohol use drugs, so until more research is done, people are advised to follow up on the medicines there and agree properly now, says Hindershot.
Topics:
